Life Company vs. Debt Fund: How They Actually Price a $10M to $25M Value-Add Deal

Why This Is Not Really a Choice Between Two Lenders

Most articles that compare life company debt to debt fund debt frame it as a menu: pick one, get a quote, close. For a stabilized, income-producing asset, that framing works fine. For a genuine value-add deal in the $10 million to $25 million range, it is the wrong frame entirely. The real question is not which lender is better. It is which lender is right for which phase of your business plan, and how you sequence the two so you are not caught financing a transitional asset with permanent capital, or holding expensive bridge debt on a stabilized building because you never lined up the takeout.

Sponsors who execute this well treat the capital stack as a relay, not a single leg. The debt fund carries the deal through repositioning. The life company (or agency, or CMBS conduit) takes the baton once the asset has proven out. Understanding how each side actually prices, and what triggers the handoff, is the difference between a deal that compounds equity and one that gets stuck mid-cycle paying floating-rate interest on an asset that should already be refinanced.

Why Life Companies Structurally Cannot Touch True Value-Add

Life insurance companies lend out of their general account against long-dated liabilities: annuities and policies they expect to pay out in ten, twenty, thirty years. That balance sheet structure dictates everything about how they underwrite. They hold loans to maturity. They do not securitize, and they do not mark to market the way a CMBS trust does. That stability is exactly why they can offer rates that run 25 to 75 basis points below CMBS for a comparable stabilized asset, typically in the 5.40% to 6.25% range at 55% to 65% loan-to-value, depending on property type and market.

The tradeoff for that pricing advantage is that life companies underwrite to in-place, durable cash flow. They size proceeds against a debt yield floor, generally 8.5% to 10.0% depending on asset type, calculated off actual trailing income, not a pro forma. A partially leased building mid-renovation, a property with a rent roll that assumes a business plan has already worked, or an asset with meaningful capital needs simply does not clear that bar. It is not that life companies dislike value-add sponsors. It is that their capital source structurally cannot absorb the execution risk of a business plan that has not yet been proven, and their internal credit committees are not built to underwrite construction draws, lease-up risk, or renovation budgets.

What a Debt Fund Is Actually Pricing For

Debt funds exist precisely to underwrite the risk life companies will not touch. They are institutional platforms, typically managing several hundred million to several billion dollars of capital from pension funds, insurance companies, and other sophisticated investors, and they are underwriting the business plan itself: the renovation scope, the contractor relationships, the lease-up velocity assumptions, and the exit comparables, not just the day-one rent roll.

That underwriting flexibility is priced accordingly. Senior bridge debt from institutional debt funds generally runs SOFR plus 275 to 500 basis points, with the tighter end of that range reserved for experienced sponsors with clean assets and conservative business plans, and the wider end reflecting either higher leverage or more execution risk. Loan-to-cost typically runs 65% to 75%, with some funds stretching to 80% or 85% for the strongest sponsors, often layering in mezzanine debt or preferred equity to reach that higher leverage point. Most senior bridge loans to institutional sponsors are non-recourse with standard carve-outs, interest-only, and close in two to four weeks for a clean deal with a recent appraisal and title already in order, versus 45 to 90 days for a life company loan working through committee.

The speed and flexibility are not incidental. A value-add sponsor competing for a deal against an all-cash buyer or another leveraged bidder needs certainty of execution on a tight timeline. A life company, moving through a multi-week credit committee process built around a stabilized asset, simply is not built for that.

The Bridge-to-Permanent Sequence, Priced Out

The sophisticated move, and the one that actually separates institutional-grade execution from a sponsor leaving money on the table, is lining up the permanent takeout before you need it, not after. There are two ways this typically gets structured on a $10 million to $25 million value-add deal:

Forward commitment at closing. Some life companies and agency lenders will issue a forward commitment on the permanent loan at the same time the debt fund closes the bridge, locking in the takeout rate and terms conditioned on the asset hitting a defined stabilization threshold, typically a minimum debt yield or occupancy level within an 18 to 36 month window. This costs a commitment fee and some structuring complexity, but it removes interest rate risk and refinance risk from the business plan entirely. The sponsor knows on day one what the exit financing looks like.

Refinance at stabilization. The more common path is simply executing the business plan on debt fund capital, then running a competitive refinance process once the asset clears the income and occupancy thresholds that make it a fit for permanent capital again. This gives the sponsor optionality (rates may have moved favorably, or a different capital source may offer better terms by then) at the cost of some uncertainty about where rates and spreads will actually sit when the asset stabilizes.

Either way, the trigger point is the same: once the asset produces a debt yield and occupancy profile that a life company, agency lender, or CMBS conduit can underwrite off trailing cash flow, sitting on floating-rate bridge debt any longer than necessary is pure cost with no corresponding benefit. Every month of delay past stabilization is a month of paying a value-add premium on an asset that no longer carries value-add risk.

A Worked Example: An $18 Million Value-Add Multifamily Deal

Consider a 120-unit multifamily acquisition in a secondary market, purchased for $18 million with a business plan to renovate units, push rents, and stabilize occupancy over 24 months.

Acquisition and renovation (debt fund, months 0 to 24): A senior bridge loan at roughly 70% loan-to-cost, priced around SOFR plus 325 to 375 basis points, non-recourse with standard carve-outs, interest-only, with a future-funding component structured into the facility to draw down renovation capital as units are completed and re-leased. Close in three to four weeks from signed application.

Stabilization (month 18 to 24): Renovated units lease up at the pro forma rents, occupancy clears 90% plus, and trailing 12-month net operating income now supports a debt yield above the 8.5% to 9.0% range most permanent lenders require at target leverage.

Takeout (life company or agency, month 24 onward): A 10-year fixed-rate permanent loan at roughly 55% to 65% loan-to-value, priced in the 5.65% to 6.25% range depending on where the 10-Year Treasury and life company spreads sit at the time, non-recourse, with a 30-year amortization schedule. The sponsor has converted a floating-rate, execution-risk loan into a fixed-rate, long-duration loan that matches the asset's new profile as a stabilized, income-producing property.

The sponsor who lines up that takeout in advance, or who at minimum starts the refinance conversation 90 to 120 days before the asset clears stabilization thresholds, captures that pricing improvement the moment it is available. The sponsor who waits until the bridge loan's maturity date is approaching is negotiating from a position of urgency, not leverage.

Where Sponsors Get This Wrong

The most common execution mistake is not a financing mistake at all: it is a timeline mistake. Sponsors underestimate how long lease-up actually takes, run past their bridge loan's maturity or extension options, and end up negotiating a refinance or extension from a position of weakness rather than strength. Build real contingency into your bridge loan term (most institutional bridge loans include one or two 12-month extension options for exactly this reason) and start the takeout conversation well before you need the capital, not after your existing loan is 60 days from maturity.

The second most common mistake is treating the bridge lender selection as a commodity decision based purely on rate. The debt fund you choose should have a track record of actually closing forward commitments or facilitating clean handoffs to permanent capital, not just competitive bridge pricing. A broker or capital markets team that maintains relationships across both the debt fund landscape and the life company, agency, and CMBS landscape can run that handoff as a coordinated process rather than two disconnected financings.

The Takeaway for Your Next $10 Million to $25 Million Deal

Life companies and debt funds are not competing for the same deal at the same moment. They are built for different phases of the same asset's life. The sponsors who consistently outperform on value-add deals are not the ones who found the cheapest bridge loan. They are the ones who priced the entire capital stack, acquisition through stabilized takeout, as a single sequenced plan from day one.

If you have a value-add acquisition in the $10 million to $25 million range and want a frank read on how to sequence bridge and permanent capital for your specific business plan, contact the CLS CRE team. We work across 1,000 plus lender relationships, including institutional debt funds and life company desks, and we build the full capital stack, not just the next quote.